Article
The First Patient in the Veteran Affairs System to Receive Chimeric Antigen Receptors T-cell Therapy for Refractory Multiple Myeloma and the Role of Intravenous Immunoglobulin in the Prevention of Therapy-associated Infections
- Author:
- Christi Swierenga, MSN, AOCNP:,
Publish date: September 9, 2024